We, the undersigned, commend you for your leadership, commitment to reducing out-of-control prescription drug prices, and efforts to stop anti-competitive abuses that keep drug prices high for patients. We were encouraged by the Senate Judiciary Committee’s bipartisan approval of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974) last Congress. On the reintroduction of this legislation in the 116th session of Congress, we again pledge our support for the CREATES Act and look forward to continuing to work with you to get this bill across the finish line this year.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
